- Home
- GMAB vs WLK Comparison
GMAB vs WLK Comparison
Compare GMAB & WLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMAB
- WLK
- Stock Information
- Founded
- GMAB 1999
- WLK 1986
- Country
- GMAB Denmark
- WLK United States
- Employees
- GMAB N/A
- WLK N/A
- Industry
- GMAB Biotechnology: Pharmaceutical Preparations
- WLK Major Chemicals
- Sector
- GMAB Health Care
- WLK Industrials
- Exchange
- GMAB Nasdaq
- WLK Nasdaq
- Market Cap
- GMAB 12.8B
- WLK 11.9B
- IPO Year
- GMAB N/A
- WLK 2004
- Fundamental
- Price
- GMAB $19.88
- WLK $82.09
- Analyst Decision
- GMAB Buy
- WLK Buy
- Analyst Count
- GMAB 9
- WLK 14
- Target Price
- GMAB $39.17
- WLK $110.43
- AVG Volume (30 Days)
- GMAB 1.5M
- WLK 1.0M
- Earning Date
- GMAB 05-08-2025
- WLK 05-02-2025
- Dividend Yield
- GMAB N/A
- WLK 2.57%
- EPS Growth
- GMAB 85.27
- WLK 50.25
- EPS
- GMAB 17.68
- WLK 3.00
- Revenue
- GMAB $3,135,137,804.00
- WLK $12,013,000,000.00
- Revenue This Year
- GMAB $17.69
- WLK N/A
- Revenue Next Year
- GMAB $14.81
- WLK $6.51
- P/E Ratio
- GMAB $1.12
- WLK $27.61
- Revenue Growth
- GMAB 51.92
- WLK N/A
- 52 Week Low
- GMAB $17.24
- WLK $77.23
- 52 Week High
- GMAB $30.41
- WLK $161.31
- Technical
- Relative Strength Index (RSI)
- GMAB 48.84
- WLK 40.18
- Support Level
- GMAB $18.89
- WLK $80.00
- Resistance Level
- GMAB $19.67
- WLK $87.32
- Average True Range (ATR)
- GMAB 0.49
- WLK 2.97
- MACD
- GMAB -0.12
- WLK 0.30
- Stochastic Oscillator
- GMAB 34.61
- WLK 29.75
About GMAB Genmab A/S ADS
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.
About WLK Westlake Corporation
Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.